Clinical Trial Update: Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Gefitinib in combination with chemotherapy for advanced or recurrent colorectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Gefitinib (Iressa) (gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 2 | Status: TERMINATED